Broker Research
November 26, 2025 / 14:37 IST
Reported Consolidated quarterly numbers for Panacea Biotec are:Net Sales at Rs 141.13 crore in September 2025 down 4.22% from Rs. 147.35 crore in September 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 13.92 crore in September 2025 down 390% from Rs. 4.80 crore in September 2024.
EBITDA stands negative at Rs. 11.39 crore in September 2025 down 197.77% from Rs. 11.65 crore in September 2024.
Panacea Biotec shares closed at 345.15 on November 24, 2025 (NSE) and has given -36.38% returns over the last 6 months and -19.02% over the last 12 months.
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Sep'25 | Jun'25 | Sep'24 | | Net Sales/Income from operations | 141.13 | 166.70 | 147.35 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 141.13 | 166.70 | 147.35 | | EXPENDITURE | | Consumption of Raw Materials | 46.58 | 72.71 | 41.77 | | Purchase of Traded Goods | 1.91 | 2.01 | -- | | Increase/Decrease in Stocks | 10.45 | 2.50 | 1.42 | | Power & Fuel | -- | -- | -- | | Employees Cost | 47.71 | 45.72 | 43.44 | | Depreciation | 8.34 | 8.39 | 8.68 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 52.27 | 44.94 | 53.72 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -26.13 | -9.57 | -1.68 | | Other Income | 6.40 | 5.67 | 4.65 | | P/L Before Int., Excpt. Items & Tax | -19.73 | -3.90 | 2.97 | | Interest | 2.14 | 0.86 | 0.98 | | P/L Before Exceptional Items & Tax | -21.87 | -4.76 | 1.99 | | Exceptional Items | 2.70 | 11.32 | 2.77 | | P/L Before Tax | -19.17 | 6.56 | 4.76 | | Tax | -5.16 | 2.60 | 0.05 | | P/L After Tax from Ordinary Activities | -14.01 | 3.96 | 4.71 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -14.01 | 3.96 | 4.71 | | Minority Interest | 0.09 | 0.09 | 0.09 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -13.92 | 4.05 | 4.80 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.27 | 0.66 | 0.77 | | Diluted EPS | -2.27 | 0.66 | 0.77 | | EPS After Extra Ordinary | | Basic EPS | -2.27 | 0.66 | 0.77 | | Diluted EPS | -2.27 | 0.66 | 0.77 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
